Literature DB >> 26345753

Association of the genetic polymorphisms of NFKB1 with susceptibility to ovarian cancer.

L P Chen1, P S Cai2, H B Liang1.   

Abstract

Nuclear factor-κB (NF-κB), a transcription factor that is activated by various stimuli, is associated with the pathogenesis of several cancers. One functional polymorphism, -94 insertion/deletion ATTG (rs28362491), in the human NFKB1 gene (one member of the NF-κB gene family) is associated with increased risk of various cancers. However, only one study has reported that rs28362491 is significantly associated with ovarian cancer. The aim of this study was to analyze the association between single nucleotide polymorphisms (SNPs) and haplotypes in the NFKB1 gene and the risk of ovarian cancer in a Chinese population. We examined the potential association between ovarian cancer and 15 SNPs (rs28362491, rs3774932, rs1598856, rs230531, rs230530, rs230528, rs230521, rs230498, rs230539, rs1005819, rs3774956, rs4648055, rs4648068, rs3774964, rs3774968) of the NFKB1 gene using the MassARRAY system. Participants included 411 patients with ovarian cancer and 438 healthy controls. The results showed that the allelic or genotypic frequencies of three polymorphisms, including rs28362491 (promoter region), rs230521 (intron 4), and rs4648068 (intron 12), in the patients with ovarian cancer, were significantly different from those in the healthy controls. Strong linkage disequilibrium was observed in four blocks (D' > 0.9). Significantly more A-C (block 2: rs230528-rs230521) haplotypes (P = 0.0003 after Bonferroni's corrections) and G-A-A (block 4: rs4648068-rs3774964-rs3774968) haplotypes (P = 0.021) were found in the patients with ovarian cancer. These findings point to a role of the NFKB1 polymorphism in patients with ovarian cancer among a Chinese Han population, and may be informative for future genetic or biological studies on ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26345753     DOI: 10.4238/2015.July.27.15

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  8 in total

1.  Cytokine Gene Polymorphisms Associated With Various Domains of Quality of Life in Women With Breast Cancer.

Authors:  Kimberly Alexander; Yvette P Conley; Jon D Levine; Bruce A Cooper; Steven M Paul; Judy Mastick; Claudia West; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2017-09-23       Impact factor: 3.612

2.  Association and interaction of NFKB1 rs28362491 insertion/deletion ATTG polymorphism and PPP1R13L and CD3EAP related to lung cancer risk in a Chinese population.

Authors:  Jiaoyang Yin; Huiwen Wang; Ulla Vogel; Chunhong Wang; Wei Hou; Yegang Ma
Journal:  Tumour Biol       Date:  2015-11-13

Review 3.  An updated meta-analysis of 37 case-control studies on the association between NFKB1 -94ins/del ATTG promoter polymorphism and cancer susceptibility.

Authors:  Yi-Qiao Luo; Duan Wang; Teng Gong; Jiang Zhu
Journal:  Oncotarget       Date:  2016-09-06

4.  Analysis of 12 variants in the development of gastric and colorectal cancers.

Authors:  Giovanna C Cavalcante; Marcos At Amador; André M Ribeiro Dos Santos; Darlen C Carvalho; Roberta B Andrade; Esdras Eb Pereira; Marianne R Fernandes; Danielle F Costa; Ney Pc Santos; Paulo P Assumpção; Ândrea Ribeiro Dos Santos; Sidney Santos
Journal:  World J Gastroenterol       Date:  2017-12-28       Impact factor: 5.742

Review 5.  NFKB1 -94insertion/deletion ATTG polymorphism and cancer risk: Evidence from 50 case-control studies.

Authors:  Wen Fu; Zhen-Jian Zhuo; Yung-Chang Chen; Jinhong Zhu; Zhang Zhao; Wei Jia; Jin-Hua Hu; Kai Fu; Shi-Bo Zhu; Jing He; Guo-Chang Liu
Journal:  Oncotarget       Date:  2017-02-07

6.  NF-κB1 Rs28362491 Mutant Allele Frequencies along the Silk Road and Beyond.

Authors:  Safoora Pordel; Kazem Nemati; Mohammad Hossein Karimi; Mehrnoosh Doroudchi
Journal:  Iran J Public Health       Date:  2018-03       Impact factor: 1.429

7.  Genetic association between NFKB1 -94 ins/del ATTG Promoter Polymorphism and cancer risk: a meta-analysis of 42 case-control studies.

Authors:  Duan Wang; Tianhang Xie; Jin Xu; Haoyang Wang; Weinan Zeng; Shuquan Rao; Kai Zhou; Fuxing Pei; Zongke Zhou
Journal:  Sci Rep       Date:  2016-07-22       Impact factor: 4.379

Review 8.  NFKB1 and Cancer: Friend or Foe?

Authors:  Julia Concetti; Caroline L Wilson
Journal:  Cells       Date:  2018-09-07       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.